Profil
Christophe Bonny founded Xigen SA in 2002 and held the title of Wissenschaftler from 2002 to 2009.
He is also the founder of Phi Pharma SA. Bonny's former jobs include Research Fellow at Northwestern University, Head-Medical Genetics Research at the University of Lausanne, and Chief Scientific Officer at Bicycle Therapeutics Plc.
Bonny received a doctorate from Université de Neuchâtel.
Postes actifs de Christophe Bonny
| Sociétés | Poste | Début |
|---|---|---|
Phi Pharma SA
 Phi Pharma SA Pharmaceuticals: MajorHealth Technology The Swiss company was founded by Emmanuel Savioz, Patrick Berdoz, Christophe Bonny, and Fabrice Chenaux. The CEO is Franco Merkling. | Fondateur | - |
Anciens postes connus de Christophe Bonny
| Sociétés | Poste | Fin |
|---|---|---|
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - |
| BICYCLE THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | - |
| University of Lausanne | Corporate Officer/Principal | - |
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Directeur Général | - |
Formation de Christophe Bonny
| Université de Neuchâtel | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BICYCLE THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Phi Pharma SA
Phi Pharma SA Pharmaceuticals: MajorHealth Technology The Swiss company was founded by Emmanuel Savioz, Patrick Berdoz, Christophe Bonny, and Fabrice Chenaux. The CEO is Franco Merkling. | Health Technology |
